BiondVax moves ahead with universal flu vaccine on two fronts
This article was originally published in Scrip
Executive Summary
BiondVax's potentially game-changing universal flu vaccine is likely to be of increasing interest to potential pharmaceutical partners following two new developments, according to CEO Dr Ron Babecoff.